Velasco Kelly, Torsvik Janniche, St-Louis Johanna L, Baghestani Sarah, Silvander Jonas S G, Kulkarni Rohit N, Toivola Diana M, Molven Anders
Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway.
Department of Pathology, Haukeland University Hospital, Bergen, Norway.
BMC Mol Cell Biol. 2025 Jun 5;26(1):18. doi: 10.1186/s12860-025-00544-w.
Short-chain 3-hydroxyacyl-CoA dehydrogenase (SCHAD) is a ubiquitously expressed mitochondrial enzyme with a role in the degradation of fatty acids. Because the protein also is a negative regulator of insulin secretion in pancreatic β-cells, inactivating mutations in the SCHAD gene (HADH) cause congenital hyperinsulinism of infancy (CHI) and severe hypoglycemia. Here we sought to identify novel interaction partners of SCHAD that might be particularly relevant for the endocrine pancreas.
Employing the SCHAD protein as bait, we performed yeast 2-hybrid screening of a cDNA library made from human islets of Langerhans. Surprisingly, the screening revealed the intermediate filament protein keratin 8 (K8) as a putative interaction partner of SCHAD with very high confidence. Previous reports have linked K8 to glucose homeostasis, and we confirmed the SCHAD interaction by co-immunoprecipitation in HEK293 cells. SCHAD and K8 expression were then characterized in the human β-cell model EndoC-βH1. By using proximity ligation assay, we demonstrated that stimulating the cells with a high level of glucose triggered a transient increase in the interaction. However, when studying knockout mice, we found that the loss of either K8 or SCHAD did not change the expression level of the other interaction partner. Still, when K8 knockout mice were challenged with a ketogenic diet, upregulation of SCHAD expression was blunted compared to the upregulation observed in wildtype littermates.
We propose that the SCHAD protein interacts with K8 in a way that might be relevant for proper functioning of the pancreatic β-cell. Whether the SCHAD-K8 interaction influences the phenotype of CHI remains to be demonstrated.
短链3-羟基酰基辅酶A脱氢酶(SCHAD)是一种广泛表达的线粒体酶,在脂肪酸降解中起作用。由于该蛋白也是胰腺β细胞中胰岛素分泌的负调节因子,SCHAD基因(HADH)的失活突变会导致婴儿期先天性高胰岛素血症(CHI)和严重低血糖。在此,我们试图鉴定SCHAD的新型相互作用伙伴,这些伙伴可能与内分泌胰腺特别相关。
以SCHAD蛋白为诱饵,我们对来自人胰岛的cDNA文库进行了酵母双杂交筛选。令人惊讶的是,筛选结果显示中间丝蛋白角蛋白8(K8)是SCHAD的假定相互作用伙伴,可信度非常高。先前的报道已将K8与葡萄糖稳态联系起来,我们通过在HEK293细胞中的免疫共沉淀证实了SCHAD的相互作用。然后在人β细胞模型EndoC-βH1中对SCHAD和K8的表达进行了表征。通过使用邻近连接分析,我们证明用高水平葡萄糖刺激细胞会引发相互作用的短暂增加。然而,在研究基因敲除小鼠时,我们发现K8或SCHAD的缺失均未改变另一个相互作用伙伴的表达水平。尽管如此,当用生酮饮食对K8基因敲除小鼠进行挑战时,与野生型同窝小鼠中观察到的上调相比,SCHAD表达的上调受到抑制。
我们提出,SCHAD蛋白与K8的相互作用方式可能与胰腺β细胞的正常功能有关。SCHAD-K8相互作用是否影响CHI的表型仍有待证实。